AREDS 配方((哈佛)新適樂葉黃素等抗氧化劑)被證實對中度及重度老年性黃斑病變(AMD)有益。
Benefit of AREDS formula confirmed in intermediate, advanced AMD
This analysis of the AREDS study evaluated the 10-year effect of the AREDS formulation of high-dose antioxidants and zinc supplement on AMD progression. They found the benefit persisted over 10 years, reducing the risk of developing neovascular AMD or advanced AMD, but not central geographic atrophy. The authors continue to recommend the AREDS formulation for those with intermediate AMD or advanced AMD in one eye and for those at moderate to high risk of developing advanced AMD. Ophthalmology, August 2013